Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Examine funds that maximize after-tax gains for retirement. This overview focuses on tax efficiency and long-term retirement growth.
27,329 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A notable pullback in semiconductor stocks has sharpened the buying case for a diversified chip ETF. As earnings beat...
Want to furnish on a budget without sacrificing style? This guide shares 10 practical tips to find tips best deals us...
States expand aid to middle-income buyers as mortgage costs and home prices stay elevated. The shift broadens access ...
Soccer has overtaken baseball in U.S. popularity, a shift that could reshape family entertainment budgets and the val...
The Senate Banking Committee will markup the Clarity Act, confronting more than amendments filed as lawmakers debate ...
Florida challenges to the Rooney Rule intensify a national debate over DEI policies in sports. Investors and sponsors...
Bitcoin and the broader crypto market face renewed volatility as four pivotal drivers emerge this week, including cor...
Wingstop has slumped 60% in the last year amid a negative equity balance sheet. Meanwhile, three asset-heavy stocks—r...
SUI has introduced gasless stablecoin transfers, eliminating on-chain fees for supported assets and expanding enterpr...
OpenAI is moving toward a potential trillion-dollar IPO, with confidential SEC filings reportedly underway and a Sept...
A stubborn drought threatens the nation’s largest oil export hub in Corpus Christi, forcing lawn bans and possible em...